Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Press Release Zymeworks Announces Participation In Upcoming Investor Conferences is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Zymeworks Announces Participation in Upcoming Investor Conferences
VANCOUVER, British Columbia--(BUSINESS WIRE)--Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management ... Read More
Zymeworks Announces Participation in Upcoming Investor Conferences ...
VANCOUVER, British Columbia, March 26, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional ... Read More
Zymeworks Inc. Announces Participation in Upcoming Investor Conferences ...
Zymeworks Inc. Announces Participation in Upcoming Investor Conferences in March 2025 February 25, 2025 — 06:11 am EST Written by None for Quiver Quantitative -> ... Read More
Zymeworks Announces Participation in Upcoming Investor Conferences
VANCOUVER, British Columbia — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will participate ... Read More
Zymeworks Announces Participation in Upcoming Investor Conferences
VANCOUVER, British Columbia, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today ... Read More
Zymeworks Announces Participation in Upcoming Investor Conference
VANCOUVER, British Columbia, July 03, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus